A Phase IV, 6-Week, Randomised, Double-Blind, Multicentre, Parallel Group, Comparative Study to Evaluate the Efficacy of Rosuvastatin 5mg and Atorvastatin 10mg in UK [United Kingdom] Asian Subjects With Primary Hypercholesterolaemia.
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Rosuvastatin (Primary) ; Atorvastatin
- Indications Hypercholesterolaemia; Lipid metabolism disorders
- Focus Therapeutic Use
- Acronyms SHUKRA
- Sponsors AstraZeneca
- 30 Mar 2010 Actual patient number (55) added as reported by ClinicalTrials.gov.
- 01 Aug 2008 Status changed from in progress to discontinued as reported by ClinicalTrials.gov.
- 04 Dec 2007 Status changed from recruiting to in progress according to ClinicalTrials.gov.